Cantata Superselective Microcatheter Unveiled

Committed to advancing the field of interventional radiology, Cook Medical unveiled its Cantata Superselective Microcatheter at the Society of Interventional Radiology’s 36th Annual Scientific Meeting. Engineered to complement Cook’s portfolio of minimally invasive embolization products and coils, the Cantata offers a combination of support and torqueability to help interventional radiologists navigate tortuous anatomies, while minimizing trauma with distal softness and microwire tracking.

“Interventional radiologists are at the forefront of advancing minimally invasive procedures and play a critical role in improving patient outcomes,” says Dan Sirota, vice president and global leader of Cook Medical’s Interventional Radiology division. “As a leader in embolic therapies, Cook Medical is proud to provide interventional radiologists with tools like Cantata to advance their field of medicine.”

Accepting .018" embolization coils, the Cantata allows coil delivery and can be used in combination with a wide range of emobolization products, including Cook Medical’s MicroNester® and Tornado Microcoils. Designed to be Lipiodol and dimethyl sulfoxide (DMSO) compatible, the Cantata microcatheter can be used in a range of procedures. The kink-resistant braided construction along the entire length of the shaft provides improved torque response and trackability for vessel selection while maintaining catheterization. With a hydrophilic coating designed to reduce surface friction, the 2.8 and the 2.5 French catheter lines can achieve a flow rate as high as 3.5mL/sec and 1.6 mL/sec, respectively. The five durometer zones, more than any other microcatheter, deliver a distinct yet seamless transition from the shaft to the soft, distal tip, reducing the risk of trauma.

The Cantata Superselective Microcatheter received U.S. Food and Drug Administration clearance in December of 2010.